Which prescription drugs and supplements deserve review before starting a compounded GLP-1?

Before starting a compounded GLP-1, review all insulin, sulfonylureas, and oral medications with your physician to manage potential drug interactions.

How GLP-1s Can Affect Other Medications

GLP-1 receptor agonists like semaglutide and tirzepatide work in part by slowing down gastric emptying, the process by which stomach contents move into the small intestine. This action contributes to feelings of fullness and is a key mechanism for weight loss and glycemic control.

This same mechanism can alter the absorption of medications taken by mouth. By delaying the stomach's emptying time, a GLP-1 can affect how quickly and how much of an oral drug is absorbed into your bloodstream. This is considered a class-wide effect for GLP-1 agonists.

While this interaction is not clinically significant for most drugs, it requires careful consideration for medications that need to be absorbed quickly or have a narrow therapeutic window. A thorough review of all your medications with your physician is essential before starting therapy.

Increased Risk of Hypoglycemia

The most critical drug interaction with GLP-1s is an increased risk of hypoglycemia (low blood sugar). GLP-1s stimulate insulin secretion from the pancreas in response to glucose. When combined with other medications that also lower blood sugar, this effect is amplified.

This risk is highest when GLP-1s are taken concurrently with insulin or a class of oral diabetes drugs called sulfonylureas. Common sulfonylureas include glimepiride (Amaryl), glipizide (Glucotrol), and glyburide (Diabeta, Glynase).

Under physician supervision, the dose of insulin or a sulfonylurea is often proactively reduced when initiating a GLP-1 to mitigate this risk. Your prescribing physician will provide specific guidance on dose adjustments and blood glucose monitoring.

It is vital to recognize the symptoms of hypoglycemia, which include shakiness, sweating, rapid heartbeat, confusion, dizziness, and hunger. Discuss how to manage a potential hypoglycemic event with your doctor before you begin treatment.

Impact on Oral Drug Absorption

The delayed gastric emptying caused by GLP-1s can significantly impact oral drugs with a "narrow therapeutic index." These are medications where small fluctuations in blood concentration can render them ineffective or cause toxicity.

Warfarin (Coumadin), a common blood thinner, is one such drug. Changes in its absorption can affect its anticoagulant properties. Physicians typically recommend more frequent monitoring of the International Normalized Ratio (INR) after starting a GLP-1 or changing its dose.

Levothyroxine, a thyroid hormone medication, is another example. Its absorption is best on an empty stomach. Your physician may advise you to continue taking levothyroxine 30 to 60 minutes before your first meal and other medications to ensure consistent absorption.

The FDA label for tirzepatide notes that the efficacy of oral hormonal contraceptives may be reduced. It recommends using a non-oral contraceptive method or adding a barrier method for 4 weeks after starting the drug and for 4 weeks after each dose increase.

Reviewing Supplements and Over-the-Counter Products

Full disclosure of all over-the-counter (OTC) products and dietary supplements is just as important as reviewing prescription drugs. Their effects can be unpredictable and may interact with GLP-1 therapy, even if they seem benign.

Certain supplements, including berberine, chromium, and cinnamon, are sometimes taken to support blood sugar control. When combined with a potent medication like a GLP-1, they could theoretically increase the risk of hypoglycemia.

Fiber supplements, such as psyllium (Metamucil) or methylcellulose (Citrucel), can also impact gastric emptying and may exacerbate common GLP-1 side effects like bloating, gas, or constipation. Your physician can provide guidance on managing these effects.

Always consult your physician before adding or stopping any supplement while on a GLP-1 program. You can find more information about GLP-1s in our comprehensive GOAL.MD /answers articles.

Bottom line

A complete and transparent discussion with your physician about all prescription drugs, over-the-counter medications, and supplements is a critical safety step before beginning a physician-supervised compounded GLP-1 program.

Medications that lower blood sugar (insulin, sulfonylureas) and certain oral drugs with narrow therapeutic windows (warfarin, levothyroxine, oral contraceptives) require the most careful review and management.

It's important to understand that compounded medications are prepared in licensed U.S. pharmacies to meet individual patient needs but are not FDA-approved. The FDA has not verified the safety or effectiveness of compounded GLP-1s.

This article is for educational purposes only and is not a substitute for professional medical advice. Consult a healthcare provider for any health concerns.

Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.